Research participant lifts weight in stroke rehab study

Muscle and tendon properties in stroke

RESEARCH STUDY

We are seeking individuals for a study aiming to investigate the mechanical properties of muscles and tendons in the leg. We hope to understand more about how the length and stiffness of muscles change with contracture after stroke and how that affects the ability to function. Our study uses non-invasive and pain-free techniques to measure musculoskeletal architecture. This includes having an ultrasound scan as well as an MRI scan.

To be considered for this study, participants must
• have a stroke-related ankle contracture, OR
• display typical motor development and be free of lower limb musculoskeletal pathology

Participants will be asked to undergo a single session of testing that will take place at NeuRA. The study lasts for approximately 2 hours. Participants will be reimbursed $50 and have their transportation/parking expenses paid.
If you would like to learn more about this study, please contact Arkiev D’Souza at 02 9399 1832 or a.dsouza@neura.edu.au

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

‘Progressive. Incurable. Terminal. Nothing matters… I am going to die.’

‘There are days that I just cry like a baby. I’m meant to be the provider, the strong one. No son should have to change the underwear of their 57 year old father.’ Shin Liu is a man you want to know... kind, articulate and with love in his heart. At 57 years old however, Shin has planned his funeral. Two years ago, Shin was diagnosed with motor neurone disease (MND). Unlike many cancers or heart disease, there is not a single thing the medical profession can do to stop MND. This excruciating disease twists and contorts the human body in the most horrific way, and it quickly destroys the ability to move, speak, swallow and breathe. Life expectancy post diagnosis is 2.5 years. But NeuRA researchers are making exciting progress toward it's defeat. After years of meticulous research, we've learnt that in more than 90% of MND cases a protein called TDP-43 is responsible for the changes in motor neurones. In pre-clinical (non-human) trials, we have found that this protein can be controlled by a specially engineered peptide sequence (i.e. medication) which has the potential to stop MND in its tracks. But here is the most exciting development… we are observing improvements in movement, behaviour and memory upon administering this medication! This is innovative, ground-breaking research and we need your help to accelerate this research, which will in time enable clinical trials in people living with MND. Will you support or research today?
APPEAL